A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss. While alarming, medical experts say this shedding is typically temporary and linked to rapid weight loss rather than the medications themselves. … Read more
Starting something new can feel like standing at the edge of unfamiliar territory, and beginning a GLP-1 weight loss journey is no exception. You may have done your research, talked to friends, or scrolled through countless articles. But when the moment … Read more
The U.S. government just made some big changes to how it defines healthy eating. On January 7, 2026, HHS and the USDA released the Dietary Guidelines for Americans, 2025-2030, marking one of the most significant shifts in federal nutrition policy in decades. … Read more
Your injections are on track. Your eating habits have shifted. You’re more active than before. But when you check the scale, the number looks the same as it did last week. It’s frustrating, but it doesn’t always mean something is wrong. “Why am I not losing weight on … Read more
Staying ahead of the rapidly developing scientific evidence is central to how Ivím Health delivers care. Our clinical team does not simply prescribe medication; they continuously evaluate new research to ensure patients receive guidance grounded in the latest evidence. As 2026 approaches, … Read more
If you’ve just started semaglutide or tirzepatide, chances are you have questions about what to expect in your first few weeks. At Ivím Health, we believe in giving you straightforward answers so you can feel confident about your care. Below, we’ll answer … Read more
If you’ve been researching weight loss medications, you’ve probably seen ads for “needle-free” GLP-1 options: sublingual semaglutide drops you place under your tongue or weight loss patches you stick on your skin. They promise the benefits of some popular GLP-1 medications like Wegovy® and Zepbound® without injections. It sounds great. But do GLP-1 drops … Read more
Dr. Jessica Duncan, MD, DABOM, Medical Director at Ivím Health, recently returned to The David Webb Show on SiriusXM Patriot Channel 125. In this interview, Dr. Duncan shares perspective on the newly released 2025-2030 Dietary Guidelines for … Read more
Dr. Jessica Duncan, MD, DABOM, Medical Director at Ivím Health, recently joined The David Webb Show on SiriusXM Patriot Channel 125. In this interview, Dr. Duncan shares perspective on topics including nutrition education in medical training and … Read more
Semaglutide and tirzepatide are FDA approved treatments for weight loss that have revolutionized weight management. Research has shown that average weight loss over one year is 14.9% of total body weight with semaglutide, with more than one-third … Read more
